X
    X
    X
    X

    Zydus Cadila

    Locke Lord assisted Zydus Cadila, an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies, in the acquisition of all of the shares of stock of Sentynl Therapeutics Inc., a San Diego-based commercial-stage specialty pharma company that specializes in marketing products in the pain management segment.  Locke Lord also provided assistance to Zydus in connection with the loan facility with Bank of Tokyo-Mitsubishi UFJ, which was used to fund the transaction.  Locke Lord lawyers Sean Fifield (Los Angeles), Joseph Farside (Providence), Buddy Sanders (Houston), Juliane Dziobak, Michael Wilson and Michael Conroy (all of Chicago) worked on these transactions.
    Posted January 24, 2017

    Explore Additional Topics

    Disclaimer

    Please understand that your communications with Locke Lord LLP through this website do not constitute or create an attorney-client relationship with Locke Lord LLP. Any information you send to Locke Lord LLP through this website is on a non-confidential and non-privileged basis. Therefore, do not send or include any information in your email that you consider to be confidential or privileged.